The management of atrial fibrillation in heart failure: an expert panel consensus

被引:19
作者
Farmakis, Dimitrios [1 ,2 ]
Chrysohoou, Christina [3 ]
Giamouzis, Gregory [4 ]
Giannakoulas, George [5 ]
Hamilos, Michalis [6 ]
Naka, Katerina [7 ]
Tzeis, Stylianos [8 ]
Xydonas, Sotirios [9 ]
Karavidas, Apostolos [10 ]
Parissis, John [2 ]
机构
[1] Univ Cyprus, Shakolas Educ Ctr Clin Med, Med Sch, Palaios Dromos Lefkosias Lemesou 215-6, CY-2029 Nicosia, Cyprus
[2] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Med Sch, Heart Failure Unit,Dept Cardiol, Athens, Greece
[3] Natl & Kapodistrian Univ Athens, Hippokratio Hosp, Dept Cardiol 1, Med Sch, Athens, Greece
[4] Univ Thessaly, Dept Cardiol, Larisa, Greece
[5] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Dept Cardiol 1, Thessaloniki, Greece
[6] Univ Hosp Heraklion, Dept Cardiol, Iraklion, Greece
[7] Univ Ioannina, Sch Hlth Sci, Fac Med, Dept Cardiol 2, Ioannina, Greece
[8] Mitera Gen Hosp, Dept Cardiol, Athens, Greece
[9] Evangelismos Med Ctr, Dept Cardiol, Athens, Greece
[10] G Gennimatas Gen Hosp, Dept Cardiol, Athens, Greece
关键词
Heart failure; Atrial fibrillation; Rate control; Rhythm control; Direct oral anticoagulants; Non-vitamin K antagonist oral anticoagulants; ANTAGONIST ORAL ANTICOAGULANTS; REDUCED EJECTION FRACTION; VENTRICULAR SYSTOLIC DYSFUNCTION; CATHETER ABLATION; BETA-BLOCKERS; RENAL-FUNCTION; PATIENT CHARACTERISTICS; PROGNOSTIC-SIGNIFICANCE; RANDOMIZED EVALUATION; WARFARIN;
D O I
10.1007/s10741-020-09978-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure (HF) and atrial fibrillation (AF) often coexist, being closely interrelated as the one increases the prevalence and incidence and worsens the prognosis of the other. Their frequent coexistence raises several challenges, including under-diagnosis of HF with preserved ejection fraction in AF and of AF in HF, characterization and diagnosis of atrial cardiomyopathy, target and impact of rate control therapy on outcomes, optimal rhythm control strategy in the era of catheter ablation, HF-related thromboembolic risk and management of anticoagulation in patients with comorbidities, such as chronic kidney disease or transient renal function worsening, coronary artery disease or acute coronary syndromes, valvular or structural heart disease interventions and cancer. In the present document, derived by an expert panel meeting, we sought to focus on the above challenging issues, outlining the existing evidence and identifying gaps in knowledge that need to be addressed.
引用
收藏
页码:1345 / 1358
页数:14
相关论文
共 111 条
[1]   Predictors of in-hospital mortality in patients hospitalized for heart failure - Insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) [J].
Abraham, William T. ;
Fonarow, Gregg C. ;
Albert, Nancy M. ;
Stough, Wendy Gattis ;
Gheorghiade, Mihai ;
Greenberg, Barry H. ;
O'Connor, Christopher M. ;
Sun, Jie Lena ;
Yancy, Clyde W. ;
Young, James B. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (05) :347-356
[2]   Risk of Stroke in Patients With Heart Failure A Population-Based 30-Year Cohort Study [J].
Adelborg, Kasper ;
Szepligeti, Szimonetta ;
Sundboll, Jens ;
Horvath-Puho, Erzsebet ;
Henderson, Victor W. ;
Ording, Anne ;
Pedersen, Lars ;
Sorensen, Henrik Toft .
STROKE, 2017, 48 (05) :1161-+
[3]   Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge [J].
Ameri, Pietro ;
Canepa, Marco ;
Anker, Markus S. ;
Belenkov, Yury ;
Bergler-Klein, Jutta ;
Cohen-Solal, Alain ;
Farmakis, Dimitrios ;
Lopez-Fernandez, Teresa ;
Lainscak, Mitja ;
Pudil, Radek ;
Ruschitska, Frank ;
Seferovic, Petar ;
Filippatos, Gerasimos ;
Coats, Andrew ;
Suter, Thomas ;
Von Haehling, Stephan ;
Ciardiello, Fortunato ;
de Boer, Rudolf A. ;
Lyon, Alexander R. ;
Tocchetti, Carlo G. .
EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (05) :879-887
[4]  
[Anonymous], 2019, EUR HEART J, DOI DOI 10.1093/EURHEARTJ/EHT397
[5]  
[Anonymous], 2019, AM HEART J, DOI DOI 10.1016/J.AHJ.2019.03.013
[6]  
[Anonymous], 2017, INT J CARDIOL, DOI DOI 10.1016/J.IJCARD.2016.10.042
[7]   Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial [J].
Avezum, Alvaro ;
Lopes, Renato D. ;
Schulte, Phillip J. ;
Lanas, Fernando ;
Gersh, Bernard J. ;
Hanna, Michael ;
Pais, Prem ;
Erol, Cetin ;
Diaz, Rafael ;
Cecilia Bahit, M. ;
Bartunek, Jozef ;
De Caterina, Raffaele ;
Goto, Shinya ;
Ruzyllo, Witold ;
Zhu, Jun ;
Granger, Christopher B. ;
Alexander, John H. .
CIRCULATION, 2015, 132 (08) :624-632
[8]   Efficacy of empagliflozin on heart failure and renal outcomes in patients with atrial fibrillation: data from the EMPA-REG OUTCOME trial [J].
Boehm, Michael ;
Slawik, Jonathan ;
Brueckmann, Martina ;
Mattheus, Michaela ;
George, Jyothis T. ;
Ofstad, Anne Pernille ;
Inzucchi, Silvio E. ;
Fitchett, David ;
Anker, Stefan D. ;
Marx, Nikolaus ;
Wanner, Christoph ;
Zinman, Bernard ;
Verma, Subodh .
EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (01) :126-135
[9]   Changes in Renal Function in Patients With Atrial Fibrillation An Analysis From the RE-LY Trial [J].
Boehm, Michael ;
Ezekowitz, Michael D. ;
Connolly, Stuart J. ;
Eikelboom, John W. ;
Hohnloser, Stefan H. ;
Reilly, Paul A. ;
Schumacher, Helmut ;
Brueckmann, Martina ;
Schirmer, Stephan H. ;
Kratz, Mario T. ;
Yusuf, Salim ;
Diener, Hans-Christoph ;
Hijazi, Ziad ;
Wallentin, Lars .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (23) :2481-2493
[10]   Left Atrial Function in Preclinical Diastolic Dysfunction: Two-Dimensional Speckle-Tracking Echocardiography-Derived Results from the BEFRI Trial [J].
Brecht, Anna ;
Oertelt-Prigione, Sabine ;
Seeland, Ute ;
Ruecke, Mirjam ;
Haettasch, Robert ;
Wageloehner, Tobias ;
Regitz-Zagrosek, Vera ;
Baumann, Gert ;
Knebel, Fabian ;
Stangl, Verena .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2016, 29 (08) :750-758